Alvedia’s History

With his prestigious background in human medicine and blood banking, Dominique brought the transformative technology of human blood typing and human Gel Test method to the company.

Dominique is behind the development of the complete range of canine, feline and equine blood group monoclonal antibodies. These highly specific antibodies improve the safety and effectiveness of animal blood transfusions by ensuring compatibility between donors and recipients, thus preventing the risk of transfusion reactions.

“Our strength lies in our shared vision and values, which emphasize the reliability of our technologies”

With a rich international management experience, mainly in the USA and Switzerland, Alice is driving Alvedia to global recognition through a personal investment in the success and reputation of the business.

“The aim is to pursue excellence and maintain high standards in our operations, product reliability and scientific support for our clients worldwide”

This support likely includes everything from detailed product information and usage guidelines to troubleshooting and ongoing research findings, which can be critical for practitioners in the field.